Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. PJP
PJP logo

PJP

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PJP News

FDA Commissioner Expresses Worries Over US Pharmaceutical Industry Falling Behind China in Drug Development

Feb 18 2026stocktwits

Key Pharmaceutical Stocks to Watch as Novo Nordisk Declines

Nov 24 2025SeekingAlpha

Pharma ETFs Gain Attention After Strong Q3 Earnings Reports

Nov 14 2025NASDAQ.COM

Eli Lilly CEO Criticizes PBM 'Rent-Seeking', Claims They Increased Insulin List Prices to $275: 'We Can Easily Bypass Them'

Nov 12 2025Benzinga

Is Trump's MFN Policy Targeting Pharma ETFs?

Nov 10 2025NASDAQ.COM

Economist Warns Trump's Full Drug Tariff Will Burden Americans, Not Foreign Companies

Sep 29 2025Benzinga

Pharma Stocks Rise as Trump's Tariff Decision May Benefit the Industry

Sep 26 2025MarketWatch

Trump seeks to limit direct-to-consumer pharmaceutical advertising, potentially affecting Hims & Hers Health.

Sep 09 2025MarketWatch

Mark Cuban Reveals How Wholesalers Coerce Pharmacies into Nearly Exclusive Agreements, Highlighting PBMs' 'Stranglehold' on Medication Costs

Sep 08 2025Benzinga

Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'

Aug 01 2025Benzinga

Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'

Jul 16 2025Benzinga

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies

Jul 11 2025Benzinga

More tariff letters look set to hit. A Trump official says they’ll include a ‘general’ notice.

Jul 08 2025MarketWatch

Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'

Jun 20 2025Benzinga

These sectors look set for new tariffs, even as court blocks other Trump levies

May 29 2025MarketWatch

Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion

May 19 2025Benzinga